FR11C0047I2 - Acides 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-(4.3.0)-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinocarboxyliques eventuellement substitues et leurs derives - Google Patents

Acides 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-(4.3.0)-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinocarboxyliques eventuellement substitues et leurs derives

Info

Publication number
FR11C0047I2
FR11C0047I2 FR11C0047C FR11C0047C FR11C0047I2 FR 11C0047 I2 FR11C0047 I2 FR 11C0047I2 FR 11C0047 C FR11C0047 C FR 11C0047C FR 11C0047 C FR11C0047 C FR 11C0047C FR 11C0047 I2 FR11C0047 I2 FR 11C0047I2
Authority
FR
France
Prior art keywords
quinolinocarboxyl
nonan
diazabicyclo
cyclopropyl
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR11C0047C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Animal Health GmbH
Original Assignee
Bayer Animal Health GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1997/000637 external-priority patent/WO1997031001A1/de
Application filed by Bayer Animal Health GmbH filed Critical Bayer Animal Health GmbH
Publication of FR11C0047I1 publication Critical patent/FR11C0047I1/fr
Application granted granted Critical
Publication of FR11C0047I2 publication Critical patent/FR11C0047I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR11C0047C 1996-02-23 2011-10-04 Acides 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-(4.3.0)-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinocarboxyliques eventuellement substitues et leurs derives Active FR11C0047I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19606762 1996-02-23
DE19633805A DE19633805A1 (de) 1996-02-23 1996-08-22 Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate
PCT/EP1997/000637 WO1997031001A1 (de) 1996-02-23 1997-02-12 Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate

Publications (2)

Publication Number Publication Date
FR11C0047I1 FR11C0047I1 (ko) 2011-11-11
FR11C0047I2 true FR11C0047I2 (fr) 2013-01-11

Family

ID=7786206

Family Applications (1)

Application Number Title Priority Date Filing Date
FR11C0047C Active FR11C0047I2 (fr) 1996-02-23 2011-10-04 Acides 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-(4.3.0)-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinocarboxyliques eventuellement substitues et leurs derives

Country Status (9)

Country Link
EP (1) EP1215202A1 (ko)
KR (1) KR100493576B1 (ko)
AR (1) AR005958A1 (ko)
DE (1) DE19633805A1 (ko)
FR (1) FR11C0047I2 (ko)
HU (1) HUS1200019I1 (ko)
MY (1) MY122142A (ko)
UA (1) UA54415C2 (ko)
ZA (1) ZA971507B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499992A (en) * 1983-04-18 1985-02-19 Pixall Corporation Self-cleaning support roller for an endless conveyor belt
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
DE4019023A1 (de) * 1990-06-14 1991-12-19 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
DE19652219A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen

Also Published As

Publication number Publication date
KR19990082537A (ko) 1999-11-25
MY122142A (en) 2006-03-31
AR005958A1 (es) 1999-07-21
UA54415C2 (uk) 2003-03-17
HUS1200019I1 (hu) 2016-02-29
FR11C0047I1 (ko) 2011-11-11
DE19633805A1 (de) 1997-08-28
EP1215202A1 (de) 2002-06-19
ZA971507B (en) 1997-09-16
KR100493576B1 (ko) 2005-09-14

Similar Documents

Publication Publication Date Title
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
NL300250I1 (nl) Chinuclidinederivaten.
MX9201823A (es) Derivados de quinolina.
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
DK0920429T3 (da) Substituerede pyrido- eller pyrimidoholdige, 6,6- eller 6,7-bicykliske derivater
FI922234A0 (fi) Kompositioner med laog loeslighet, vilka utgoers av paerlor belagda med laekemedel.
NL300214I2 (nl) Chinazolinederivaten.
MA26542A1 (fr) Derives oxindole substitues.
DE122004000043I2 (de) Carbostyril-Derivate.
TR199600883A2 (tr) Pürin-6-on türevleri.
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
TR199600715A2 (tr) Kefalosforin türevleri.
FR11C0047I2 (fr) Acides 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-(4.3.0)-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinocarboxyliques eventuellement substitues et leurs derives
DE69108314D1 (de) Dihydro-Campholen-Aldehydderivate.
DE69714358D1 (de) 9,10-disubstituierte campothecinderivate mit antitumoraktivität
TR199600064A2 (tr) 4-amino-benzoilguanidin-türevleri.
DE59106761D1 (de) N-Acylpyrrolidin-Derivate.
DE58903154D1 (de) 2,2-difluorcyclopropyl-derivate.
FI922980A (fi) 2-piperidinylpyrimidin-4-karboxamidderivat, framstaellning av dessa ochterapeutisk anvaendning av dessa
TR28915A (tr) Naftokinon türevleri.
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
TR27776A (tr) 2-oksimino-2-tiyenil-asetik asit türevleri.
FI922443A0 (fi) Framstaellning av 6-0-alkylelsamicin-a -derivat.
TR27956A (tr) Hidroksietil-azolil türevleri.
ES1016628Y (es) Percha perfeccionada.